Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 901 to 925 of 2559

TitleReference numberPublishedLast updated
Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal)TA702
Ibrutinib with rituximab for untreated chronic lymphocytic leukaemia (terminated appraisal)TA703
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapiesTA704
Heavy menstrual bleeding: assessment and managementNG88
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiographyHTG429
Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcersHTG355
Ravulizumab for treating paroxysmal nocturnal haemoglobinuriaTA698
Ofatumumab for treating relapsing multiple sclerosisTA699
Crisaborole for treating mild to moderate atopic dermatitis in people 2 years and older (terminated appraisal)TA701
KODEX-EPD for cardiac imaging during ablation of arrhythmiasMIB260
Permanent His-bundle pacemaker implantation for treating heart failureHTG579
Axonics sacral neuromodulation system for faecal incontinenceMIB259
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasiaHTG578
Repetitive short-pulse transscleral cyclophotocoagulation for glaucomaHTG576
Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adultsHTG577
Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapyTA692
Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemiaTA694
Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myelomaTA695
microINR for anticoagulation therapyMIB257
Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liverHTG575
Acalabrutinib for treating chronic lymphocytic leukaemiaTA689
Avelumab for untreated metastatic Merkel cell carcinomaTA691
Avelumab for treating metastatic Merkel cell carcinomaTA517
Postnatal careNG194
Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary painNG193

Results per page

  1. 10
  2. 25
  3. 50
  4. All